Trials / Completed
CompletedNCT00002169
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
A Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Cytomegalovirus (CMV) Retinitis in AIDS Patients Who Are Receiving Standard Induction and Maintenance Therapy for This Infection
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Agouron Pharmaceuticals · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nelfinavir mesylate |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002169. Inclusion in this directory is not an endorsement.